Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis

Langley, Richard G. B. ; Reich, Kristian ; Strand, Vibeke ; Feldman, Steven R. ; Paul, Carle ; Gordon, Kenneth ; Warren, Richard B. ; Toth, Darryl ; Nikaï, Enkeleida ; Zhu, Baojin ; Goldblum, Orin ; Edson-Heredia, Emily ; Carlier, Hilde ; Burge, Russel ; Lin, Chen-Yen ; Hollister, Kristin ; Augustin, Matthias

Quality of life research, 2020-02, Vol.29 (2), p.369-380 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível